Company Ticker News July 21, 2021AbbVie (ABBV) Venclexta Gets Breakthrough Therapy Tag for MDS 0 0 Share
Press Release July 21, 2021Venetoclax (VENCLEXTA®) Granted US FDA Breakthrough Therapy Designation (BTD) in Higher Risk Myelodysplastic Syndrome (MDS) 0 0 Share
Company Ticker News July 20, 2021AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know 0 0 Share
Company Ticker News July 18, 20214 Large-Cap Healthcare Stocks You'll Want on Your Radar for the Second Half of 2021 0 0 Share
Company Ticker News July 17, 2021AbbVie, Lilly Atopic Dermatitis Treatments Hit With Further Delays With FDA 0 0 Share
Company Ticker News July 17, 2021Novartis, Eli Lilly and AbbVie Top 5-Year New Drug Productivity List 0 0 Share
Press Release July 16, 2021AbbVie Provides Update Regarding RINVOQ® (upadacitinib) for the Treatment of Moderate to Severe Atopic Dermatitis in the U.S. 0 0 Share
